UNITED STATES SECURITIES AND EXCHANGE COMMISSION TABLE OF CONTENTS WASHINGTON, D.C. 20549 _______________________ FORM 10-Q _______________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ________ Commission File Number: 001-40212 Connect Biopharma Holdings Limited (Exact name of ...